BCL2 and neoplasm: According to the immunoblotting of tumor tissue, pyrotinib suppressed the pEGFR/pSTAT3 signaling pathway, decreased CD24 protein expression, and produced alterations in apoptosis-related proteins cl-PARP and bcl2, which fully echoed the mechanism of the above in vitro experiments (Figure 5F).